ESMO MBC Guideline - Discussing the facts


EMSO MBC Guideline 2021
ESMO Plenary 2021
Update of ESMO MBC 2021 Guideline with focus on…
ESMO MBC Guideline - in 100 Seconds - ENG


EMSO MBC Guideline 2021
ESMO Plenary 2021
TNBC: what is important? Marker first!


EMSO MBC Guideline 2021
ESMO Plenary 2021
Luminal MBC: what is important?


EMSO MBC Guideline 2021
ESMO Plenary 2021
HER2+: what is important? New drugs!
ESMO MBC Guideline - in 100 Seconds - ITA/GER


EMSO MBC Guideline 2021
ESMO Plenary 2021
Update der ESMO Leitlinie 2021 zum metastasierten…


EMSO MBC Guideline 2021
ESMO Plenary 2021
Carcinoma mammario metastatico - cosa è importante?
monarchE - Discussing the facts


monarchE
ESMO Plenary 2021 MonarchE
monarchE with 27 months of FU: Practice changing -…
monarchE in 100 Seconds - ENG


monarchE
ESMO Plenary 2021 MonarchE
monarchE Update: Clinically significant and meaningful…


monarchE
ESMO Plenary 2021 monarchE
monarchE Update: Strong effect of Abemaciclib confirmed…
monarchE in 100 Seconds - GER


monarchE
ESMO Plenary 2021 monarchE
monarchE Update: Starker Effekt der Abemaciclib…
KEYNOTE-522 - Discussing the facts


ESMO Plenary 2021
KEYNOTE-522: What's new?


ESMO Plenary 2021
IMpassion031 vs. KEYNOTE-522: similar pCR, no biomarker…


ESMO Plenary 2021
CPI patient selection: CPS vs. response


ESMO Plenary 2021
What about BRCA+ TNBC? PARPi or CPI? PARPi + CPI?


ESMO Plenary 2021
Will CPI change breast cancer treatment on a global…


ESMO Plenary 2021
CPI duration? non-pCR TNBC? Global access to therapies?…
KEYNOTE-522 - in 100 Seconds


ESMO Plenary 2021
KEYNOTE-522: First CPI in TNBC with pCR and EFS…


ESMO Plenary 2021
KEYNOTE-522 - a practice changer!


ESMO Plenary 2021
KEYNOTE-522: What is new?
KEYNOTE-522 - in 100 Seconds (ESP/ITA/GER)


ESMO Plenary 2021
KEYNOTE-522: Cosa è veramente importante?


ESMO Plenary 2021
KEYNOTE-522 - praxis verändernd!


ESMO Plenary 2021
KEYNOTE-522: Que novedades hay?